Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Biktarvy3.23B46.48%
Other815M11.72%
Descovy485M6.97%
Sofosbuvir/Velpatasvir476M6.84%
Genvoya440M6.33%
Yescarta414M5.95%
Trodelvy320M4.60%
Odefsey315M4.53%
Vemlidy243M3.49%
Veklury214M3.08%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States19.44B71.68%
Europe4.31B15.89%
Other international3.37B12.42%
